Work

Higher therapeutic CsA levels early post transplantation reduce risk of acute GVHD and improves survival

Year: 2013

Type: article

Study design: Observational Study

Source: Bone Marrow Transplantation

DOI: 10.1038/bmt.2013.139

Authors: J R Rogosheske, A D Fargen, T E DeFor, E Warlick, M Arora, B R Blazar, D J Weisdorf, C G Brunstein

Institution: University of Minnesota

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Leukemia and Lymphoma Society, University of Minnesota, National Institutes of Health, National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Center for Advancing Translational Sciences

Awards: In vivo Prevention of Murine GVHD, University of Minnesota Clinical and Translational Science Institute (UMN CTSI), G2935575925, Cancer Center Support Grant, Off-the-Shelf Immune Effector Cells for Hematological Malignancies

OpenAlex ID: W2034017748

FWCI: 3.588

Cites: 22

Cited by: 50

Related to: 10